A growing body of meta-analyses pooling randomized controlled trials has compared two injectable options for knee osteoarthritis: platelet-rich plasma (PRP) and hyaluronic acid (HA). Across this pooled evidence, PRP is emerging as the injection more likely to help — though it comes with important caveats worth understanding before considering it.

What the research looked at

These analyses combined data from multiple randomized trials that directly compared intra-articular PRP injections with intra-articular HA injections in people with knee osteoarthritis. Researchers tracked how many patients reported meaningful pain relief after treatment, and how many eventually needed another procedure — such as a repeat injection or surgery — because their initial treatment did not hold up over time.

What it found

Pooled across these trials, PRP was associated with higher rates of meaningful pain relief than HA, along with lower rates of patients needing a follow-up procedure. The advantage for PRP reached statistical significance at around the 12-month mark, meaning the difference observed by that point in follow-up was unlikely to be due to chance.

What it means (and the limits)

These findings point to PRP as a promising option for some people with knee osteoarthritis, but several limits matter. PRP is not a supplement or an at-home remedy — it is an in-clinic medical procedure performed by a healthcare provider, using a sample of the patient's own blood that is processed and then re-injected into the joint. Results can vary considerably depending on exactly how the PRP is prepared, since platelet concentration and processing protocols differ between clinics and between studies, which makes it hard to compare outcomes directly across settings. PRP is also not a substitute for the fundamentals of osteoarthritis care: regular exercise, weight management, and ongoing medical follow-up remain central to managing the condition. Anyone considering PRP injections should discuss the option — including its costs, risks, and how it fits alongside other treatments — with an orthopedic specialist.

Sources: https://pubmed.ncbi.nlm.nih.gov/38420745/ · https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0314878

Dual-action joint collagen

Mafsal Riyadi combines the two collagen types most studied for joints — high-tripeptide hydrolyzed collagen and undenatured type II collagen — in one licensed dietary supplement (EDA reg. no. 14711/2026). Research about ingredient categories is general and is not a claim about any individual product.

Learn about Mafsal Riyadi

This is a plain-language summary of published research for general education. It is not medical advice, a diagnosis, or a treatment recommendation, and individual studies have limitations. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. Consult your doctor or pharmacist about your own situation.